ANI Pharmaceuticals
The goal of this clinical trial is to learn if Purified Cortrophin Gel can help people with acute gouty arthritis when they are having a sudden flare-up. It will also monitor participants for any potential side effects while on this therapy. The main question it aims to answer is: is there a change in gout pain intensity after receiving Purified Cortrophin Gel. Researchers will compare two different doses of Purified Cortrophin Gel. Participants will: * Receive one injection of Purified Cortrophin Gel * Have 2 in-person visits to the site and 3 virtual/telephone visits * Complete daily surveys about their gout flare
Main inclusion criteria: 1. Signed informed consent to participate in this study. 2. Male and female patients, aged 18-90 years. 3. Meeting the 2015 Gout classification criteria of the ACR/EULAR collaborative initiative. 4. Onset of current acute gout flare within 5 days prior to study entry 5. Baseline pain intensity ≥ 50 mm on the 0-100 mm visual analog scale (VAS). 6. History of ≥ 1 gout flares within the 12 months prior to study entry 7. The patient meets at least one of the following criteria for NSAIDs or colchicine treatment options: 1. Minimum of one episode of inadequate response…
One injection of Purified Cortrophin Gel, 40 U
One injection of Purified Cortrophin Gel, 80 U
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.